| scholarly article | Q13442814 |
| P50 | author | Zhiqiang Lin | Q56998519 |
| P2093 | author name string | Jin Zhang | |
| Amy Li | |||
| Feng Liang | |||
| Qing Ma | |||
| Aibin He | |||
| Pingzhu Zhou | |||
| William T Pu | |||
| Yuan Cao | |||
| Vassilios J Bezzerides | |||
| Yuxuan Guo | |||
| Sean M Stevens | |||
| Cristobal Dos Remedios | |||
| Qimin Quan | |||
| Sylvia Zohrabian | |||
| Haidong Guo | |||
| Nathan VanDusen | |||
| Pim R van Gorp | |||
| P2860 | cites work | Yap1 acts downstream of α-catenin to control epidermal proliferation | Q24294904 |
| The Hippo pathway regulates Wnt/beta-catenin signaling | Q24307606 | ||
| A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer | Q24337135 | ||
| L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L | Q24531160 | ||
| The Hippo Signaling Pathway in Development and Cancer | Q24603986 | ||
| Efficient biotinylation and single-step purification of tagged transcription factors in mammalian cells and transgenic mice | Q24670468 | ||
| The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP | Q28266862 | ||
| The Hippo effector Yorkie controls normal tissue growth by antagonizing scalloped-mediated default repression | Q28291847 | ||
| The cardiac tissue-restricted homeobox protein Csx/Nkx2.5 physically associates with the zinc finger protein GATA4 and cooperatively activates atrial natriuretic factor gene expression | Q28504813 | ||
| Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size | Q28507019 | ||
| YAP1 increases organ size and expands undifferentiated progenitor cells | Q28592519 | ||
| Role of YAP/TAZ in mechanotransduction | Q29615411 | ||
| Direct observation of individual endogenous protein complexes in situ by proximity ligation | Q29616032 | ||
| p300/CBP proteins: HATs for transcriptional bridges and scaffolds | Q29617981 | ||
| Elucidation of a universal size-control mechanism in Drosophila and mammals | Q29618935 | ||
| Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells | Q29619410 | ||
| Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution | Q30431585 | ||
| MCAT elements and the TEF-1 family of transcription factors in muscle development and disease | Q30444840 | ||
| Yap1 is required for endothelial to mesenchymal transition of the atrioventricular cushion. | Q33846400 | ||
| Strategies for cardiac regeneration and repair | Q34795299 | ||
| Alpha-catenins control cardiomyocyte proliferation by regulating Yap activity | Q34807247 | ||
| PRC2 directly methylates GATA4 and represses its transcriptional activity | Q35674575 | ||
| YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy | Q35787211 | ||
| Statistical analysis of the genomic distribution and correlation of regulatory elements in the ENCODE regions | Q35840712 | ||
| Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure | Q35921523 | ||
| Yes-associated protein regulates the hepatic response after bile duct ligation | Q36200492 | ||
| YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers | Q36219267 | ||
| Myocyte proliferation in end-stage cardiac failure in humans | Q36221185 | ||
| Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size | Q36231054 | ||
| Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury | Q36596197 | ||
| Hippo pathway effector Yap promotes cardiac regeneration | Q37117699 | ||
| Hippo signaling impedes adult heart regeneration. | Q37323625 | ||
| Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association | Q37538031 | ||
| Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth | Q38844916 | ||
| Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model | Q41994688 | ||
| A novel acetylation cycle of transcription co-activator Yes-associated protein that is downstream of Hippo pathway is triggered in response to SN2 alkylating agents | Q42211262 | ||
| Vgl-4, a novel member of the vestigial-like family of transcription cofactors, regulates alpha1-adrenergic activation of gene expression in cardiac myocytes. | Q42461541 | ||
| Releasing YAP from an α-catenin trap increases cardiomyocyte proliferation. | Q43090219 | ||
| Cardiomyocyte cell cycle control and growth estimation in vivo--an analysis based on cardiomyocyte nuclei | Q43195307 | ||
| Control of the hippo pathway by Set7-dependent methylation of Yap. | Q46240754 | ||
| Structures and activities of protease inhibitors of microbial origin | Q68237037 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Yes-associated protein 1 | Q21498262 |
| E1A binding protein p300 | Q21981065 | ||
| TEA domain family member 1 | Q21990678 | ||
| Vestigial like family member 4 | Q21990685 | ||
| P1104 | number of pages | 14 | |
| P304 | page(s) | 466-479 | |
| P577 | publication date | 2016-10-04 | |
| P1433 | published in | Developmental Cell | Q1524277 |
| P1476 | title | Acetylation of VGLL4 Regulates Hippo-YAP Signaling and Postnatal Cardiac Growth | |
| P478 | volume | 39 |
| Q39172264 | A growing role for the Hippo signaling pathway in the heart |
| Q101038640 | A protein tertiary structure mimetic modulator of the Hippo signalling pathway |
| Q90974961 | A reference map of murine cardiac transcription factor chromatin occupancy identifies dynamic and conserved enhancers |
| Q64068696 | A step towards understanding the molecular nature of human heart failure: advances using the Sydney Heart Bank collection |
| Q38743894 | Cardiac Regeneration: Lessons From Development |
| Q91675402 | Cell contact and Nf2/Merlin-dependent regulation of TEAD palmitoylation and activity |
| Q92154541 | Cell-Based Mechanosensation, Epigenetics, and Non-Coding RNAs in Progression of Cardiac Fibrosis |
| Q49545706 | Dysregulation of YAP by the Hippo pathway is involved in intervertebral disc degeneration, cell contact inhibition, and cell senescence |
| Q38952768 | Expression Profiling of Clinical Specimens Supports the Existence of Neural Progenitor-Like Stem Cells in Basal Breast Cancers |
| Q90735622 | Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload |
| Q52632435 | How Hippo Signaling Pathway Modulates Cardiovascular Development and Diseases. |
| Q98506393 | Hox-dependent coordination of mouse cardiac progenitor cell patterning and differentiation |
| Q58610051 | Loss of VGLL4 suppresses tumor PD-L1 expression and immune evasion |
| Q41013371 | MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy. |
| Q59335899 | Mediated nuclear import and export of TAZ and the underlying molecular requirements |
| Q98466300 | Multiple Roles of Vestigial-Like Family Members in Tumor Development |
| Q64891514 | Non-sarcomeric causes of heart failure: a Sydney Heart Bank perspective. |
| Q88034821 | Physiology of Cardiac Development: From Genetics to Signaling to Therapeutic Strategies |
| Q92027205 | Protein Quality Control Activation and Microtubule Remodeling in Hypertrophic Cardiomyopathy |
| Q38987181 | Redirecting cardiac growth mechanisms for therapeutic regeneration |
| Q98771739 | Role of YAP/TAZ in Cell Lineage Fate Determination and Related Signaling Pathways |
| Q55447872 | Serotonin and YAP/VGLL4 Balance Correlated with Progression and Poor Prognosis of Hepatocellular Carcinoma. |
| Q42162747 | Tead1 is required for maintaining adult cardiomyocyte function, and its loss results in lethal dilated cardiomyopathy. |
| Q64097525 | Tead1 is required for perinatal cardiomyocyte proliferation |
| Q90966566 | The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration |
| Q33628097 | The Hippo pathway in tissue homeostasis and regeneration |
| Q90192054 | The NOTCH1-dependent HIF1α/VGLL4/IRF2BP2 oxygen sensing pathway triggers erythropoiesis terminal differentiation |
| Q90405813 | VGLL4 is a transcriptional cofactor acting as a novel tumor suppressor via interacting with TEADs |
| Q61196538 | Validation of Osteogenic Properties of Cytochalasin D by High-Resolution RNA-Sequencing in Mesenchymal Stem Cells Derived from Bone Marrow and Adipose Tissues |
| Q91675882 | Zebrafish Vestigial Like Family Member 4b Is Required for Valvulogenesis Through Sequestration of Transcription Factor Myocyte Enhancer Factor 2c |
| Q92023843 | aYAP modRNA reduces cardiac inflammation and hypertrophy in a murine ischemia-reperfusion model |
Search more.